SIR ePoster Library

616 - Lusutrombopag is a safe treatment option for thrombocytopenia in patients with chronic liver disease undergoing a planned invasive procedure: pooled safety analysis from three studies
SIR ePoster library. Brown R. 03/28/20; 289858; 616
Dr. Robert Brown
Dr. Robert Brown
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Poster Title: Lusutrombopag is a safe treatment option for thrombocytopenia in patients with chronic liver disease undergoing a planned invasive procedure: pooled safety analysis from three studies

Poster number: 616

Category: Non-Vascular Interventions: Other

Authors: R Brown1, N Izumi2, T Kano3, T Ochiai3, M Kurosaki2, F Violi4, P Shrestha5

Keywords: 0616, Robert Brown Lusutrombopag is a safe treatment option for thrombocytopenia in patients with chronic liver disease undergoing a planned invasive procedure: pooled safety analysis from three studies Lusutrombopag is a safe treatment option for
Poster Title: Lusutrombopag is a safe treatment option for thrombocytopenia in patients with chronic liver disease undergoing a planned invasive procedure: pooled safety analysis from three studies

Poster number: 616

Category: Non-Vascular Interventions: Other

Authors: R Brown1, N Izumi2, T Kano3, T Ochiai3, M Kurosaki2, F Violi4, P Shrestha5

Keywords: 0616, Robert Brown Lusutrombopag is a safe treatment option for thrombocytopenia in patients with chronic liver disease undergoing a planned invasive procedure: pooled safety analysis from three studies Lusutrombopag is a safe treatment option for
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies